The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man
Abstract
For more than three decades, acetaminophen (INN, paracetamol) has been claimed to be devoid of significant inhibition of peripheral prostanoids. Meanwhile, attempts to explain its action by inhibition of a central cyclooxygenase (COX)‐3 have been rejected. The fact that acetaminophen acts functionally as a selective COX‐2 inhibitor led us to investigate the hypothesis of whether it works via preferential COX‐2 blockade. Ex vivo COX inhibition and pharma‐cokinetics of acetaminophen were assessed in 5 volunteers receiving single 1000 mg doses orally. Coagulation‐induced thromboxane B 2 and lipopolysaccharide‐induced prostaglandin E 2 were measured ex vivo and in vitro in human whole blood as indices of COX‐1 and COX‐2 activity. In vitro , acetaminophen elicited a 4.4‐fold selectivity toward COX‐2 inhibition (IC 50 = 113.7 μmol/L for COX‐1;IC 50 = 25.8 μmol/L for COX‐2). Following oral administration of the drug, maximal ex vivo inhibitions were 56% (COX‐1) and 83% (COX‐2). Acetaminophen plasma concentrations remained above the in vitro IC 50 for COX‐2 for at least 5 h postadministration. Ex vivo IC 50 values (COX‐1: 105.2 μmol/L; COX‐2: 26.3 μmol/L) of acetaminophen compared favorably with its in vitro IC 50 values. In contrast to previous concepts, acetaminophen inhibited COX‐2 by more than 80%, i.e. , to a degree comparable to nonste‐roidal antiinflammatory drugs (NSAIDs) and selective COX‐2 inhibitors. However, a >95% COX‐1 blockade relevant for suppression of platelet function was not achieved. Our data may explain acetaminophen's analgesic and antiinflammatory action as well as its superior overall gastrointestinal safety profile compared with NSAIDs. In view of its substantial COX‐2 inhibition, recently defined cardiovascular warnings for use of COX‐2 inhibitors should also be considered for acetaminophen.—Hinz, B., Cheremina, O., Brune, K. Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man. FASEB J. 22, 383–390 (2007)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hinz et al. (2007) demonstrated 4.4x more selectivity toward the inhibition of COX-2 (IC 50 = 25.8 µmol/L) over COX-1 (IC 50 = 113.7 µmol/ L) from in vitro assays using whole human blood [51].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
In the citing paper
“In this study, paracetamol demonstrated over 80% blockade of COX-2 activity comparable to NSAIDs and COX-2 selective inhibitors.”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
In the citing paper
“It is not clear why there are significant discrepancies in relation to inhibition of COX-1 and COX-2 activities by paracetamol as reported by Hinz et al. [51] and Mitchell et al. [33].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
Citations
Cites
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989 · cited 2×
“Attempts to explain the pharmacological action of acetaminophen as inhibition of a central COX isoform, derived from the same gene as COX-1 and referred to as COX-3 (8), have been meanwhile rejected for several reasons (9).”
BackgroundCyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
The antioxidants of human extracellular fluids
Halliwell, B., & Gutteridge, J. M. C. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90510-6 · Cited by 1,341 · cited 1×
“Thus, the presence of various enzymatic and nonenzymatic antioxidant components in human plasma (33) may explain why acetaminophen elicited the most pronounced COX-2 inhibition in human whole blood as compared to the two other experimental systems.”
ResultSerhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189 · cited 1×
“Apart from these factors, evidence for COX-2 inhibition by acetaminophen is also supported by previous findings showing that acetaminophen like indomethacin and aspirin confers the synthesis of 18R-hydroxyeicosapentaenoic acid (HEPE) and 15RHEPE through interaction with the COX-2 enzyme (34).”
ResultLangenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123 · cited 1×
“A COXindependent mechanism for the gastrointestinal toxicity of NSAIDs is further supported by findings in COX-1 knockout mice, which still develop gastric erosions in response to oral administration of indomethacin (45).”
BackgroundPharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807 · cited 2×
“A peripheral antiinflammatory action is further supported by findings showing acetaminophen as an inhibitor of nociception and edema in the rat carrageenan footpad model (27, 28), an inflammatory condition critically dependent on COX-2-derived PGs (29).”
BackgroundFLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779 · cited 2×
“Whereas the drug was first associated with a predominant suppression of PG synthesis in brain tissue ( 3 ), subsequent studies contradicted a cell-specific modulation (4 –7).”
BackgroundMethodMechanism of Action of Paracetamol
Graham, G. G., & Scott, K. F. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00008 · Cited by 648 · cited 4×
“Moreover, it turned out that acetaminophen elicits no measurable inhibition of PG formation in broken cell preparations but a profound suppression in intact cells (7).”
BackgroundInfluentialNonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
Wallace, J. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041264 · Cited by 569
Cannon, C. P., Curtis, S. P., FitzGerald, G. A., Krum, H., Kaur, A., Bolognese, J. A., Reicin, A. S., Bombardier, C., Weinblatt, M. E., van der Heijde, D., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69666-9 · Cited by 522 · cited 1×
“PGE2 is the currently most plausible explanation for the cardiovascular hazard conferred by selective and nonselective COX-2 inhibitors (20, 30).”
BackgroundPatrignani, P., Panara, M. R., Greco, A., Fusco, O., Natoli, C., Iacobelli, S., Cipollone, F., Ganci, A., Créminon, C., & Maclouf, J. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24061-7 · Cited by 518 · cited 1×
“Aliquots of heparinized whole blood from healthy volunteers were incubated with LPS (10 g/ml) plus test agent or vehicle for 24 h at 37°C (17).”
MethodSystematic review of prevalence of aspirin induced asthma and its implications for clinical practice
Jenkins, C., Costello, J., & Hodge, L. (2004) · BMJ · doi:10.1136/bmj.328.7437.434 · Cited by 451 · cited 2×
“As coxibs, acetaminophen given orally at recommended single doses elicits no toxic effect on the gastrointestinal tract (13), does not inhibit platelet function (14, 15), and hardly provocates bronchoconstriction in aspirin-sensitive asthmatics (16).”
BackgroundMethodReilly, I., & FitzGerald, G. (1987) · Blood · doi:10.1182/blood.v69.1.180.180 · Cited by 419 · cited 1×
“In fact, previous data suggest that only an excess of 95% inhibition of serum TxB2 significantly affects platelet function (35).”
Mechanism of Action of Acetaminophen: Is There a Cyclooxygenase 3?
Botting, R. M. (2000) · Clinical Infectious Diseases · doi:10.1086/317520 · Cited by 350
Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and the Risk of Cardiovascular Events
Chan, A. T., Manson, J. E., Albert, C. M., Chae, C. U., Rexrode, K. M., Curhan, G. C., Rimm, E. B., Willett, W. C., & Fuchs, C. S. (2006) · Circulation · doi:10.1161/circulationaha.105.595793 · Cited by 319 · cited 1×
“In line with this notion, a recently published large, prospective study showed that use of acetaminophen at more than 15 tablets per week confers nearly the same risk for cardiovascular events as traditional NSAIDs ( 32 ).”
ResultSomasundaram, S., Rafi, S., Hayllar, J., Sigthorsson, G., Jacob, M., Price, A. B., Macpherson, A., Mahmod, T., Scott, D., Wrigglesworth, J. M., et al. (1997) · Gut · doi:10.1136/gut.41.3.344 · Cited by 314 · cited 1×
“produce mucosal injury by uncoupling oxidative mitochondrial phosphorylation in epithelial cells, resulting in diminished cellular ATP production, cellular toxicity, and increased mucosal permeability (43).”
BackgroundAlberto García Rodríguez, L., & Hernández-Díaz, S. (2001) · Epidemiology · doi:10.1097/00001648-200109000-00018 · Cited by 307 · cited 2×
“As coxibs, acetaminophen given orally at recommended single doses elicits no toxic effect on the gastrointestinal tract (13), does not inhibit platelet function (14, 15), and hardly provocates bronchoconstriction in aspirin-sensitive asthmatics (16).”
BackgroundAcetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties
Kis, B., Snipes, J. A., & Busija, D. W. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085431 · Cited by 250 · cited 1×
“Attempts to explain the pharmacological action of acetaminophen as inhibition of a central COX isoform, derived from the same gene as COX-1 and referred to as COX-3 (8), have been meanwhile rejected for several reasons (9).”
BackgroundBoutaud, O., Aronoff, D. M., Richardson, J. H., Marnett, L. J., & Oates, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102588199 · Cited by 209 · cited 2×
“inflamed tissue, both of which diminish the effect of acetaminophen on PG synthesis (7, 23, 24).”
BackgroundClinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.
Boardman, P. L., & Hart, F. D. (1967) · BMJ · doi:10.1136/bmj.4.5574.264 · Cited by 205 · cited 1×
“In reality, this statement is based largely on early work showing that acetaminophen does not suppress inflammation associated with rheumatoid arthritis (21, 22).”
BackgroundNon-Narcotic Analgesic Dose and Risk of Incident Hypertension in US Women
Forman, J. P., Stampfer, M. J., & Curhan, G. C. (2005) · Hypertension · doi:10.1161/01.hyp.0000177437.07240.70 · Cited by 196
Influence of sex and oral contraceptive steroids on paracetamol metabolism.
Miners, J., Attwood, J., & Birkett, D. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02207.x · Cited by 184 · cited 1×
“In case of gender, however, the previously shown 22% higher clearance of acetaminophen in males as compared to females (46) is not considered to be of clinical importance.”
BackgroundMechanism of Acetaminophen Inhibition of Cyclooxygenase Isoforms
Ouellet, M., & Percival, M. D. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2232 · Cited by 166 · cited 2×
“inflamed tissue, both of which diminish the effect of acetaminophen on PG synthesis (7, 23, 24).”
BackgroundGraham, G. G., Scott, K. F., & Day, R. O. (2005) · Drug Safety · doi:10.2165/00002018-200528030-00004 · Cited by 164
Pharmacokinetics in the aged: A review
Triggs, E. J., & Nation, R. L. (1975) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059473 · Cited by 158 · cited 1×
“With respect to elderly patients, previous data indicate no age-related changes in the rate and extent of absorption and plasma clearance of acetaminophen (50).”
ResultInitial and Subsequent Dosing of Rectal Acetaminophen in Children
Birmingham, A. P. K., Tobin, M. J., Fisher, D. M., Henthorn, T. K., Hall, S. C., & Coté, C. J. (2001) · Anesthesiology · doi:10.1097/00000542-200103000-00005 · Cited by 122 · cited 1×
“In this context a previous study has shown that in children an initial rectal acetaminophen dose of 40 mg/kg followed by 20 mg/kg doses ever y6hi sneeded to achieve target antipyretic plasma concentrations ( 49 ).”
BackgroundRahme, E., Pettitt, D., & LeLorier, J. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10604 · Cited by 102 · cited 1×
“6 g, increases the risk of severe upper gastrointestinal side effects, including gastrointestinal bleeding or perforation (14, 38).”
BackgroundHinz, B., Brune, K., & Pahl, A. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3885 · Cited by 102 · cited 1×
“Mononuclear cells were isolated from heparinized human whole blood of healthy volunteers by density gradient centrifugation with Histopaque-1077 as described previously ( 18 ).”
MethodSelf-citationCOX-3: in the wrong frame in mind
Dinchuk, J. E., Liu, R. Q., & Trzaskos, J. M. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00268-7 · Cited by 100 · cited 1×
“In particular, the existence of a functional human COX-3 has been questioned, given that retention of intron 1 in human COX-3 leads to a shift in the reading frame, a premature termination, and a truncated, COX-inactive protein (10, 11).”
BackgroundUpdate of ACR Guidelines for Osteoarthritis
Schnitzer, T. J. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00372-x · Cited by 95 · cited 1×
“It is recommended as first-line therapy for pain associated with osteoarthrosis (1).”
BackgroundPlatelet dysfunction after intravenous ketorolac or propacetamol
Niemi, T., Backman, J. T., Syrjälä, M. T., Viinikka, L. U., & Rosenberg, P. H. (2000) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2000.440113.x · Cited by 79 · cited 1×
“Clinical trials reporting inhibition of platelet function by acetaminophen used high parenteral doses of the drug ( 36 , 37).”
BackgroundRing, E. F., Collins, A. J., Bacon, P. A., & Cosh, J. A. (1974) · Annals of the Rheumatic Diseases · doi:10.1136/ard.33.4.353 · Cited by 79 · cited 1×
“In reality, this statement is based largely on early work showing that acetaminophen does not suppress inflammation associated with rheumatoid arthritis (21, 22).”
BackgroundQin, N., Zhang, S.-P., Reitz, T. L., Mei, J. M., & Flores, C. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090944 · Cited by 77 · cited 1×
“(12) reported a low-level expression of three splice variants of COX-1 in human tissues but were not able to show a significantly different potency of acetaminophen in inhibiting human COX-1 vs.”
BackgroundDose-dependent Inhibition of Platelet Function by Acetaminophen in Healthy Volunteers
Munsterhjelm, E., Munsterhjelm, N., Niemi, T., Ylikorkala, O., Neuvonen, P. J., & Rosenberg, P. H. (2005) · Anesthesiology · doi:10.1097/00000542-200510000-00009 · Cited by 76 · cited 1×
“Clinical trials reporting inhibition of platelet function by acetaminophen used high parenteral doses of the drug (36, 37).”
BackgroundAspirin Versus Acetaminophen: A Comparative View
Rumack, B. H. (1978) · PEDIATRICS · doi:10.1542/peds.62.5s.943 · Cited by 73
Björnsson, G. A., Haanaes, H. R., & Skoglund, L. A. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01779.x · Cited by 68
McCormack, K., & Brune, K. (1987) · Archives of Toxicology · doi:10.1007/bf01234664 · Cited by 67
Self-citationParacetamol versus placebo: Effects on post-operative course
Skjelbred, P., & L�kken, P. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00563555 · Cited by 66 · cited 1×
“On the other side, acetaminophen decreases tissue swelling following oral surgery in humans, with activity very similar to that of ibuprofen ( 25 , 26).”
BackgroundLau, G. S. N., & Critchley, J. (1994) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(94)00859-0 · Cited by 61 · cited 1×
“Acetaminophen was analyzed by high-performance liquid chromatography (HPLC) with ultraviolet (UV) detection following a previously published method (19).”
MethodCOX‐3—a virtual pain target in humans?
Schwab, J. M., Beiter, T., Linder, J. U., Laufer, S., Schulz, J. E., Meyermann, R., & Schluesener, H. J. (2003) · The FASEB Journal · doi:10.1096/fj.03-0595lte · Cited by 59 · cited 1×
“In particular, the existence of a functional human COX-3 has been questioned, given that retention of intron 1 in human COX-3 leads to a shift in the reading frame, a premature termination, and a truncated, COX-inactive protein (10, 11).”
BackgroundHonoré, P., Buritova, J., & Besson, J. (1995) · Pain · doi:10.1016/0304-3959(95)00065-8 · Cited by 58 · cited 1×
“model (27, 28), an inflammatory condition critically dependent on COX-2-derived PGs (29).”
BackgroundHinz, B., Dormann, H., & Brune, K. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21540 · Cited by 55 · cited 3×
“However, a significant impact seems unlikely given that a virtually complete COX-2 inhibition was observed in a comparable group of elderly probands (50 to 60 years) following an 8-day treatment with antirheumatic doses of diclofenac (20).”
BackgroundSelf-citationWarner, T. D., Vojnovic, I., Giuliano, F., Jiménez, R., Bishop‐Bailey, D., & Mitchell, J. A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063875 · Cited by 51
Actions of paracetamol on cyclooxygenases in tissue and cell homogenates of mouse and rabbit.
Swierkosz, T. A., Jordan, L., McBride, M. L., McGough, K., Devlin, J., & Botting, R. M. (2002) · PubMed · Cited by 47
Comparative effects of aspirin and acetaminophen on hemostasis
Mielke, C. H. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.141.3.305 · Cited by 42 · cited 4×
“As coxibs, acetaminophen given orally at recommended single doses elicits no toxic effect on the gastrointestinal tract (13), does not inhibit platelet function (14, 15), and hardly provocates bronchoconstriction in aspirin-sensitive asthmatics (16).”
BackgroundInfluentialGastrointestinal safety of paracetamol: is there any cause for concern?
Bannwarth, B. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.4.269 · Cited by 39
Antipyretic analgesics inhibit prostaglandin release from astrocytes and macrophages similarly
Lanz, R., Polster, P., & Brune, K. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90188-3 · Cited by 35
Self-citationComparative Effects of Aspirin and Acetaminophen on Hemostasis
Mielke, C. H. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340030037008 · Cited by 33
Mantzke, U., & Brambrink, A. M. (2002) · Der Anaesthesist · doi:10.1007/s00101-002-0359-9 · Cited by 28
Abramson, S. B. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10609 · Cited by 28 · cited 1×
“from this data because of several confounding factors, including the more common use of acetaminophen in patients at higher risk for gastrointestinal complications ( 39 ).”
BackgroundSh, F., Lorenzetti, B. B., & Corrêa, F. M. D. A. (1978) · PubMed · Cited by 26
Kang, K. B., van der Zypp, A., Iannazzo, L., & Majewski, H. (2006) · Translational research · doi:10.1016/j.trsl.2006.06.004 · Cited by 17 · cited 1×
“A more general issue constitutes an age-related increase in COX-2 expression that has been recently observed in human mononuclear cells, with a 70% increase in the older age group (51).”
Background
Research works printed but not linked: 1
- Mantzke U. S., 2002, Paracetamol in childhood. Current state of knowledge and indications for a rational approach to postoperative analgesia, Anaesthesist, 51, 735
Cited by
Mechanisms of drug combinations: interaction and network perspectives
Jia, J., Zhu, F., Ma, X., Cao, Z. W., Li, Y. X., & Chen, Y. Z. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2683 · Cited by 969
Rao, P., & Knaus, E. E. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3t886 · Cited by 773
“However the final jury on this question is not out yet (78, 79).”
BackgroundGraham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
Multiple Functions of Endocannabinoid Signaling in the Brain
Katona, I., & Freund, T. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150420 · Cited by 630
“…the highly potent analgesic effects of nonsteroidal anti-inflammatory drugs (NSAIDs) like paracetamol (acetaminophen), a selective COX-2 inhibitor (Hinz et al., 2008), or ibuprofen, a potent inhibitor of 2-AG oxidation by COX-2 (Prusakiewicz et al., 2009) require the activation of CB1 receptors…”
BackgroundNew insights into the use of currently available non-steroidal anti-inflammatory drugs
Brune, & Patrignani, P. (2015) · Journal of Pain Research · doi:10.2147/jpr.s75160 · Cited by 469
“38,39 42 Inhibition of prostanoid biosynthesis by NSAIDs is responsible for the therapeutic activities of these drugs; 11,32 however, this inhibitory activity also suppresses other effects of these prostanoids, resulting in the side effects associated with NSAID treatment.”
Metadata
- Authors
- Hinz, B., Cheremina, O., & Brune, K.
- Affiliations
- University of Rostock (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- ORCID
- Hinz, Burkhard
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-09-20
- Volume
- 22
- Issue
- 2
- Pages
- 383-390
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2132889863
- Cited by
- 478
- References
- 51
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 15 · 2023: 14 · 2022: 19 · 2021: 19 · 2020: 14 · 2019: 28 · 2018: 33 · 2017: 29 · 2016: 35 · 2015: 49 · 2014: 28 · 2013: 33 · 2012: 36
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- paracetamol, COX-2 inhibition, COX-1 inhibition, COX-2 inhibitors, thromboxane B2, prostaglandin E2, plasma pharmacokinetics, gastrointestinal safety, cardiovascular risk, analgesic mechanism, anti-inflammatory mechanism
- MeSH terms
- Acetaminophen, Cells, Cultured, Humans, Isoenzymes, Monocytes, Time Factors, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.